Role of myositis-specific autoantibodies in personalized therapy
In a landmark breakthrough in 1976, Reichlin and Mattioli discovered the first myositis-specific antibody (MSA) called anti-Mi2 antibody that identified a specific clinical phenotype characterized by pathognomonic skin rash of dermatomyositis, typical proximal muscle weakness, good response to treat...
Guardat en:
| Autors principals: | , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
SAGE Publishing
2018-01-01
|
| Col·lecció: | Indian Journal of Rheumatology |
| Matèries: | |
| Accés en línia: | http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2018;volume=13;issue=3;spage=186;epage=194;aulast=Malaviya |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|